Medtronic Suspends Endurant Evo Study To Investigate Stent Fractures
This article was originally published in Clinica
Executive Summary
One patient short of its final enrollment goal, Medtronic has suspended its global clinical study of the next-generation Endurant Evo stent graft to investigate a higher-than-anticipated rate of stent fractures.